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 Abstract 
Glycosylation is the most common 
posttranslational modification of proteins and 
consists of the addition of sugar moiety to proteins. 
The resulting glycosylated proteins are often 
secreted to the extracellular compartment or 
integrated into different cell organelles. This 
modification was identified in plant as well as in 
mammalian cells.  A number of plant and mammal 
proteins are either N- or O-glycosylated. This 
review focuses on O-glycosylation which refers to 
linkage of a glycan to hydroxyl group of serine, 
threonine or proline residues. O-glycosylation can 
be altered by the action of chemical inhibitors. For 
instance, 3,4-dehydro-L-proline, ethyl 
3,4-dehydroxy benzoate and α,α-dipyridyl inhibit 
the activity of prolyl4-hydroxylase, a key enzyme 
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for plant O-glycosylation. In addition, a small 
molecule inhibitor designated 1-68A inhibits the 
polypeptide N-acetylgalactosaminyltransferases of 
mammalian cells. The aim of this review is to 
summarize the role and mechanism of action of 
these inhibitors of O-glycosylation and their impact 
on cell development in plants and mammals. 
Keywords: O-glycosylation; 3,4-dehydro-L-proline; 
3,4-dehydroxybenzoate; prolyl-hydroxylase; 
N-acetyl-galactosaminyltransferases; α,α-dipyridyl 
Abbreviations:  
PTM: posttranslational modification 
ER: endoplasmic reticulum 
HRGPs: hydroxyproline-rich glycoproteins 
AGPs: arabinogalactan-proteins 
Hyp: hydroxyproline 
P4-Hs: prolyl-4-hydroxylases 
Ser/Thr: serine/threonine 
GalNAc-Ts: N-acetylgalactosaminyltransferases 
3,4-DHP: 3,4-dehydro-L-proline 
3,4-EDHB: ethyl-3,4-dehydroxy benzoate 
DP: α,α-dipyridyl 
GalNAc-O-bn: benzyl-N-acetyl-a-galactosamide 
ppGNTases: polypeptide N-acetylgalactosaminyltransferases 
 
Introduction 
Protein glycosylation is one of the major 
posttranslational modification (PTM) occurring in 
eukaryotic cells (from unicellular to multicellular 
organisms). This PTM which generally follows/ 
accompanies the synthesis of polypeptides in the 
endoplasmic reticulum (ER) is initiated in this same 
compartment, and completed in the Golgi apparatus. 
Glycosylated proteins follow the secretory pathways 
and are either released in the extracellular 
compartments (plasma membrane, cell wall, cell surface 
matrix) or destined to different organelles within the 
cell (e.g., lysosomes, vacuoles). Both N-linked and 
O-linked glycosylation processes have been found and 
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Fig. 1. O-linked glycans in the process of general O-glycosylation in the plant and mammalian cells 
(Wilson Iain, 2002; Kirk Bergstrom and Xia, 2013) 
studied in plant and animal cells. N-glycosylation is very 
well described and has been the object of many studies, 
reviews and biotechnological applications (Strasser, 
2009; Bardor et al., 2010; Gomord et al., 2010), whereas 
O-glycosylation is less studied in general, and is the focus 
of this paper. O-glycosylated proteins are known to play 
important functions in animal and plant cells including 
cell-cell interactions, signaling, recognition, and 
scaffolding. Protein glycosylation is also required for 
maintaining the folding, the stability and the activity of 
secreted proteins (Apweiler et al., 1999; Haltiwanger 
and Lowe, 2004). The structure of O-linked glycans of 
plant versus animal glycoproteins is quite different 
(summarized in Fig. 1). 
In plants, O-glycosylated proteins have been 
abundantly reported within a family of secreted cell 
wall proteins, the hydroxyproline-rich glycoproteins 
(HRGPs). HRGPs constitute a superfamily composed of 
arabinogalactan-proteins (AGPs), extensins, and 
proline-rich proteins (Showalter et al., 2010; Xu et al., 
2008; Velasquez et al., 2011). HRGPs are variably 
glycosylated (Showalter, 1993). These proteins undergo 
an essential modification namely the conversion of 
proline residues into hydroxyproline (Hyp) by a 
multigene family of enzymes, the prolyl-4-hydroxylases 
(P4-Hs) (Vlad et al., 2007) that act within the 
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endoplasmic reticulum and the Golgi apparatus. The Hyp 
residues are then glycosylated either with 
arabinogalactan chains, with short arabinan chains, or 
with single galactose residues by different 
glycosyltransferases in the Golgi apparatus (Shpak et al., 
1999; Showalter, 2001; Wilson Iain, 2002; Velasquez et 
al., 2011; Velasquez et al., 2012). Molecular genetics 
approaches coupled to analytical techniques have 
shown that glycosylation of Hyp residues is dependent 
on a variety of consensus motifs widespread within the 
peptide amino acid sequence. O-glycosylation leading to 
arabinosylation occurs on clustered Ser-(Hyp)4 
contiguous sequences (contigs), whereas 
O-glycosylation leading to arabinogalactosylation occurs 
on Hyp-alanine, Hyp-serine, Hyp-threonine and 
Hyp-valine contigs (Kieliszewski and Shpak, 2001; 
Shpak et al., 2001; Tan et al., 2003; Tan et al., 2004; 
Estévez et al., 2006; Xu et al., 2008). 
In mammals, O-glycosylation is not predominantly 
found on proline residues; it does also occur on 
serine/threonine (Ser/Thr), tyrosine and hydroxylysine 
amino acids. The most common of these modifications 
is the mucin-type O-glycosylation, which is widespread 
in the animal kingdom (Bennett et al., 2012). In 
mammals, initiation of mucin-type O-glycosylation can 
be performed by up to 20 different UDP-GalNac 
polypeptide N-acetylgalactosaminyltransferases 
(GalNAc-Ts) which catalyze the transfer of a single 
N-acetylgalactosamine (GalNAc) residue to 
serine/threonine amino acids (GalNAcα Ser/Thr). 
Further elongation of GalNAc residues is performed by 
Golgi-located glycosyltransferases and results in 
different O-glycan structures including core 1 to core 4 
structures. Mucin-type O-linked glycoproteins are 
involved in many biological processes such as the 
regulation of serum half-life of cytokine, the alteration 
of glycans on cancer cells and the lubrication of variety 
of intestinal tissues. Mucins play structural role and 
contribute to mechanical properties, organization, and 
shape of tissues, and interact with cells via different 
receptors. They also regulate their migration, 
proliferation, and differentiation (Ricard-Blum, 2010). 
O-glycosylation has also been well studied on collagen, 
which is the most abundant proteins in mammals 
(~30% of total protein mass in certain cells). Collagen 
contains more than 10% of proline residues. It does also 
contain lysine residues. The enzymes which hydroxylate 
these amino acids are the prolylhydroxylase and 
lysylhydroxylase (Ricard-Blum, 2010; Rosenbloom and 
Prockop, 1970). 
Understanding O-protein glycosylation has direct 
implications in basic research but also in several areas 
of biotechnology, including molecular pharming, or 
novel strategies of plant/crop protection. Progress in 
such an understanding has been facilitated by different 
approaches including molecular genetics and 
pharmacological approaches. Here, we have chosen to 
present some drugs/inhibitors which have been used to 
unravel plant and mammal O-glycosylation. Prospects in 
application, especially in plant biotechnology, are also 
presented. 
 
Inhibiting O-glycosylation in plants using chemical 
inhibitors 
P4-Hs perform a key step in plant O-glycosylation, which 
is the hydroxylation of proline residues. Direct or 
indirect inhibition of the action of this enzyme has been 
used to study the function of O-glycosylation in plants. 
To interfere with the process of O-glycosylation, various 
substances have been employed including 
3,4-dehydro-L-proline (3,4-DHP), ethyl-3,4-dehydroxy 
benzoate (3,4-EDHB) and α,α-dipyridyl. 
3,4-DHP is an analog of proline which can be 
incorporated into the polypeptide chain, and rapidly 
and irreversibly inhibits peptidyl proline 
hydroxylation. 3,4-DHP has been shown to inhibit 
P4-Hs action in plant cells when applied at micromolar 
concentrations (Cooper and Varner, 1983). The authors 
have shown that treatment of discs of phloem 
parenchyma tissue from roots of Daucus carota with 
5µM and 50µM 3,4-DHP  inhibits the hydroxylation of 
proline by 70% and 90% , respectively. An unpublished 
study has shown that 3,4-DHP-treated tobacco BY-2 
cells were able to alter the molecular weight as well as 
the carbohydrate composition of secreted AGPs 
(Aboughe-Angone Sophie, Nguema-Ona Eric, Azeddine 
Driouich, article in preparation).  3,4-DHP  treatment of 
soybean cells  was also shown to induce  disappearance 
of the major PRPs from the cell wall of cultured cells 
(Schmidt et al., 1991), and 3,4-DHP-treated protoplasts 
do not develop osmotic stability and do  initiate 
mitosis.  3,4-DHP-treated carrot root cells continue to 
synthesize and secrete structurally abnormal extensin 
HRGPs that might be expected to function abnormally 
(Cooper et al., 1994). Others studies showed that 
treatment of onion root cells by 3, 4-DHP resulted on a 
56% decrease in hydroxyproline content (Tullio et al., 
1999). Recently, Xu et al. (2011), have shown that 
3,4-DHP inhibited the proliferation of embryogenic 
cells of banana and decreased the rate of embryo 
germination. In the context of plant microbe 
interactions, 3,4-DHP has been used to investigate the 
role of plant AGPs in root colonization by soil 
rhizobacteria (Vicré et al., 2005). It has been shown 
that 3,4-DHP induced alteration of AGP glycosylation 
and altered rhizobacteria ability to colonize Arabidopsis 
roots (Nguema-Ona et al., 2013). Altogether, these 
studies showed that inhibition/alteration of plant 
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Fig. 2. Initiation of mucin-type O-linked glycosylation biosynthesis by the ppGalNAc-Ts which utilize 
UDP-GalNAc as the nucleotide sugar donor and modify protein substrates (Hang and Bertozzi, 2005; 
Tian et al., 2004) 
O-glycosylation by 3,4-DHP treatment affects many 
aspects of plant development and interaction with 
microbes. Interestingly, in mammalian cells, proline 
hydroxylation in collagen is also inhibited by 3,4-DHP 
treatment (see below). 
O-glycosylation in the plant cells can also be inhibited 
by ethyl-3,4-dehydroxy benzoate (3-4-EDHB) and 
α,α-dipyridyl (DP) (Velasquez et al., 2011). 3,4-EDHB 
binds to the active site of prolyl4-hydroxylase, while 
α,α-dipyridyl (DP) chelates a co-factor required for 
P4-Hs activity. Velazquez et al.  have shown that 
transgenic Arabidopsis roots expressing the fusion 
LeAGP1::GFP treated at nanomolar range (48 to 219 nM) 
with these two drugs exhibited 50% growth inhibition 
of their root hairs. These treatments also caused the 
accumulation of non-glycosylated ~ 42 KD forms of 
LeAGP1-GFP and fully O-glycosylated ~ 150 to 200 KD 
form. The authors also linked the absence of 
O-glycosylation of extensins in the p4-h Arabidopsis 
mutants to the abnormal root hair phenotype observed. 
Altogether, these studies show that the use of 
O-glycosylation inhibitors in plants affect considerably 
various aspects of growth and survival supporting the 
importance of the O-glycosylation in the function of 
plant cells.   
  
Inhibiting O-glycosylation in mammals using 
chemical inhibitors 
In mammals, proline, but also serine, threonine, and 
tyrosine amino acids can be O-glycosylated. Different 
enzymes perform the addition of glycosidic residues on 
the polypeptidic backbones. Therefore, different drugs 
targeting different key enzymes have also been 
identified and used to study mammal-specific 
O-glycosylation. Collagens and mucins are well studied 
mammal-O-glycosylated proteins. Interestingly, collagen 
O-glycosylation often occurs on Hyp residues while 
mucin O-glycosylation occurs on serine or threonine 
residues. 
Rosenbloom and Prockop (1970) have studied the 
effect of 3,4-DHP treatment on collagen O-glycosylation. 
They have found that 3,4-DHP decreased the 
hydroxylation of proline and lysine residues in collagen 
and that the altered collagen could not be extruded from 
cartilage cells as rapidly as that of control samples.  The 
effects observed following 3,4-DHP treatment were 
comparable to those observed with 
azetidine-2-carboxylic acid and cis-4-fluoroproline 
(analog of proline) but were slightly less pronounced 
(Takeuchi and Prockop, 1969, Takeuchi et al., 1969). In 
the study on collagen synthesis and prolyl hydroxylase 
activity in mammalian cell cultures, Kerwar and Felix 
(1976) showed that, in addition to decreasing the 
hydroxylation of proline residues and the secretion of 
collagen from cells, 3,4-DHP also inhibited the 
incorporation of glycine and lysine into collagen. 
3,4-DHP also   prevented excessive collagen deposition 
during wound healing and inhibited fibrosis 
development (Kerwar and Felix, 1976). 
By contrast with collagen-type O-glycosylation, 
mucin-type O-glycosylation occurs on serine and 
threonine residues, and occurs also on many other 
glycoproteins (Tarp and Clausen, 2008). This type of 
O-glycosylation constitutes the most common type of 
O-linked glycosylation found in mammals and other 
eukaryotes (Hang and Bertozzi, 2005). Here, 
glycosylation is initiated by the ppGNTases. These are 
enzymes that initiate mucin-type O-linked glycosylation 
by transfer of GalNAc from the nucleotide donor 
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Table 1: Possible functions in plant and mammalian cells 
Role of O-glycosylation in Plant cell walls Role of O-glycosylation in mammalian cells 
- protein stability   
- somatic embryogenesis 
- cell division and cell expansion 
- reproductive development 
- abiotic stress responses 
- xylem differentiation 
- hormone signaling pathways 
- protein stability 
- heat resistance 
- protein expression and processing 
- protease resistance 
- cellular interactions 
- hydrophilicity and antigenicity 
- modulation of enzymes activity  
 
UDP-GalNAc to Ser/Thr residues of a polypeptide 
substrate, as shown in Fig. 2 (Tian et al., 2004). This 
enzyme plays a pivotal role in cell-cell communication 
and tissue protection (Hang et al., 2004). They have 
identified a small molecule (1-68A) from a 
uridine-based library, which inhibits 
N-acetylgalactosaminyltransferases in mammalian cells 
and consequently disrupts O-glycosylation. To define the 
biological roles of the GalNAc-Ts, Tian et al. (2004) 
subjected NIH3T3 mouse fibroblast cells to 1-68A. The 
authors observed a marked decrease of protein 
glycosylation and induction of cell apoptosis. 
Over-expression of certain isoforms of GalNAc-Ts 
restored cell surface glycosylation and rescued the 
inhibitor-induced apoptosis suggesting that the 
enzymes and O-glycosylation have an important role in 
the regulation of apoptosis. Also, inhibition of 
O-glycosylation seems to play a key role in the growth of 
cancer cells (Patsos et al., 2005). For instance, 
benzyl-N-acetyl-a-galactosamide (GalNAc-O-bn) inhibits 
the O-gylcosylation of KL-6 mucin which is implicated in 
the development of aggressive metastasis in human 
pancreatic carcinoma (Xu et al., 2008).  
 
Comparative functional aspects of plant and 
mammal O-glycosylated proteins 
Plant and mammalian O-glycans are usually considered 
as structurally different, but the studies of 
O-glycosylation inhibitors in the mammalian and plant 
cells show that both plant and animal O-glycosylations 
are involved in the stability and the conformation of 
glycoproteins. In the case of extensins, O-glycosylation 
appears to stabilize the helical conformation whereas 
incomplete hydroxylation of O-glycosylation would 
promote a flexible and disorganized conformation 
(Velasquez et al., 2011). It has been suggested that 
O-glycans increase HRGPs solubility and thermal 
stability as well as resistance to proteolytic degradation 
(Ferris et al., 2001; Kieliszewski et al., 2010; Lamport et 
al., 2011). In recent studies, it has been shown that 
O-glycosylation of hydroxyproline residues increase the 
thermal stability of the prolyproline type II helix and the 
presence of β-O-glycosylated proteins indicated an 
increase in conformational stability (Owens et al., 2010; 
Velasquez et al., 2011). Interestingly plant 
O-glycosylated proteins are also suggested to play active 
role in plant defense mechanisms and signaling 
(Nguema-Ona et al., 2013). PTMs of O-glycosylated cell 
wall proteins are important to cell differentiation and 
plant development. O-glycosylated proteins like 
arabinogalactan-proteins and extensins are involved in 
the regulation of plant growth, somatic embryogenesis, 
and development processes, cell division and cell 
expansion, reproductive development, biotic and abiotic 
stress responses, xylem differentiation, and hormone 
signaling pathways (Seifert and Roberts, 2007; Zhang et 
al., 2008; Ellis et al., 2010; Velasquez et al., 2011; Xu et 
al., 2011; Velasquez et al., 2012). The slightest inhibition 
or the disruption of this PTM affects the process in 
which these molecules are involved in plant 
development. However, O-glycosylation type defines the 
glycomodules responsible for their shape, size, stability, 
and biological functions in HRGPs. 
These functions are similar in the mammalian cells. 
Several examples can illustrate the role of 
O-glycosylation in mammalian cells. In general, O-linked 
glycans maintain protein stability, heat resistance, 
antigenicity, cellular interactions, hydrophilicity, and 
modulation of enzymatic activity and protease 
resistance by steric hindrance, protein expression and 
processing (Van den Steen et al., 1998; Wopereis et al., 
2006). O-glycosylation would induce the extended and 
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Table 2: Chemical structures of inhibitors that are commonly used to inhibit plants or mammalians 
O-glycosylation 
 
STRUCTURES NAMES ABBREVIATIONS 
 
 
PROLINE 
 
P 
 
 
3,4-DEHYDRO-L-PROLINE 
 
3,4-DHP 
 
 
ETHYL-3,4-DEHYDROXY BENZOATE 
 
3,4-EDHB 
 
 
α,α-DIPYRIDYL 
 
DP 
 
 
 
BENZYL-N-ACETYL-a-GALACTOSAMIDE 
 
GalNAc-O-bn 
 
 
AZETIDINE-2-CARBOXYLIC ACID 
 
ACA 
 
 
 
CIS-4-FLUOROPROLINE 
 
FP 
 
rigid conformation in the mucin-1 which is a 
polymorphic, highly glycosylated, type I transmembrane 
glycoprotein and this allows this molecule to interfere 
with cell-cell and cell-matrix interactions (Tarp and 
Clausen, 2008). Another important function of O-linked 
sugars is to mediate recognition between proteins. 
O-glycosylation is also essential for the expression or 
biological activity of many proteins. For example, 
O-glycans influence the expression of glycophorin A at 
the cell surface of human erythrocytes (Remaley et al., 
1991), or the biological activity of interleukin-5 
(Kodama et al., 1993) and human lactase phlorizin 
hydrolase (Naim and Lentze, 1992). Altered 
glycosylation directly leads to development of certain 
diseases such as hematological disorders, 
Wiskott-Aldrich syndrome and cancer (Tsuboi and 
Fukuda, 2001; Berger, 1999; Brockhausen, 1999). 
O-linked glycans are also known to have an effect on 
immunologic recognition, for example, the ABO blood 
group antigens and recognition by antibodies (van den 
Steen et al., 2000). In addition, O-glycosidic structures 
play an important role in the localization and traffic of 
proteins, and make them more resistant to proteases, 
increase their stability, avoid or reduce the effects 
related to oxidation, denaturation by pH, precipitation or 
aggregation. A specific glycan may be involved in 
several functions in different places and different times 
(Varki, 1993). The different possible functions of 
O-glycosylation are summarized in Table 1. 
In Table 2, we summarize also the structure of 
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chemical inhibitors commonly used to inhibit plant or 
mammalian O-glycosylation. 
General Conclusions 
Protein glycosylation in general and O-glycosylation in 
particular, is a fundamental process for the function 
plant and mammalian cells. O-glycosylation alteration in 
directly impacts cell development and survival of living 
organisms. In plants, such an alteration affects plant 
development. Moreover O-glycosylated plant cell wall 
proteins play an important role in plant survival. In 
mammals, O-glycosylation accompanies many secreted 
proteins that have important roles in signaling and 
communication. Proper O-glycosylation is also often 
directly responsible for the biological activities of these 
proteins. The use of chemical inhibitors, in combination 
with molecular genetics approaches and analytical 
chemistry, has largely contributed to the study of the 
structure and function of O-glycosylated proteins. 
Understanding and harnessing O-glycosylation has 
implications in production of O-glycosylated 
biopharmaceuticals for mammal therapy. Given their 
natural ability to perform O-glycosylation, plants are 
suitable candidate for the production of therapeutic 
glycoproteins requiring O-glycans (Gomord et al., 2010; 
Sola and Griebenow, 2010; Strasser, 2013). A recent 
study has described O-glycosylation of a recombinant 
human IgA1 expressed in transgenic maize (Karnoup et 
al., 2005). Addition of small arabinan chains (via an 
addition of Hyp residues to the polypeptide sequence) to 
therapeutic polypeptides expressed in plants was also 
shown to increase the half-life of the recombinant 
molecule and its activity. 
Plant O-glycosylated proteins such as AGPs have also 
emerged as interesting players in plant defense against 
soil pathogens (Nguema-Ona et al., 2013). Thus, future 
applied research in plants should evaluate the possibility 
of massive production of O-glycosylated proteins of 
interest. 
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